Clinical Trial Update: Anti-HIV Activity and Safety of 3 Different Doses of Mifepristone in HIV Infected People [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating three different doses of mifepristone for anti-HIV activity and safety in HIV-infected individuals has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Mifepristone (mifepristone)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 1, Phase 2 | Status: COMPLETED